Search Results for: Clinical Roundup
-
Misfolded Amyloid Proteins Threaten Many Amyloidosis Diseases, Notably Liver, Heart
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Encouraged by tests on animals and in healthy human volunteers," the New York Times dated Jan. 31, 2003 reported, "the researchers are about to begin clinical trials on patients with the twoBy David N. Leff | BioWorld Today | Monday, February 10, 2003 -
Ecopia Drills Deep Into Genome- Based, High-Throughput System To Reveal Antitumor Enediynes
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Results of their double-blind, placebo-controlled clinical trial are reported in the current issue of The Lancet, dated Jan. 25, 2003...The number of patients enrolled was small, so larger clinical trials should be done to confirm our findingsBy David N. Leff | BioWorld Today | Monday, February 3, 2003 -
Is Sex Really Overrated? Yes And No, Testify Cultured Mutant Yeasts, Relying On Asexual Reproduction
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Recent advances in the use of tumor-specific immunotherapies, such as the monoclonal antibody Herceptin, have shown clinical efficacy for the treatment of metastatic mammary malignancies overexpressed by breast cancer tumorsBy David N. Leff | BioWorld Today | Wednesday, January 29, 2003 -
European Drug Agency Develops 2-Year Program For Working Party
Highlights of the initiatives that are likely to have the most impact on firms developing biotechnology medicines in Europe include updates to the existing guidance on comparability of medicines containing biotechnology-derived proteins as drug substance (as well as contributing to meetings of the EU ad hoc group dealing with clinical and preclinical issues of comparability...In terms of gene therapy and cell therapy, the plans include further advice on the quality and the preclinical and clinicalBy Peter O'Donnell | BioWorld International | Wednesday, January 29, 2003 -
Texans Use Phage-Display Screen To Design Antibody Blood Test For Prostate Cancer Management
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Novel tools for biochemically staging disease would help physicians and patients evaluate and select the most appropriate clinical approach...Ten years later, in 1754, a controlled clinical trial on another British vessel, fed 12 scurvy patients a variety of foodsBy David N. Leff | BioWorld Today | Thursday, January 16, 2003 -
Scrutinizing Brain Slices Removed From Living Epileptic Patients May Offer Prospect Of Seizure Therapy
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...AVI plans clinical trials against HCV in 2003By David N. Leff | BioWorld Today | Monday, December 23, 2002 -
A New Gig For Antibodies: Killing Off Pathogens Without Added Aid From Conventional Immune Cells
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...A controlled clinical trial invited 2,763 subjects with coronary disease to enroll in the cognitive function substudy...Clinical trials are currently in progress to determine if estrogen therapy reduces the risk of developing Alzheimer's disease and other forms of dementiaBy David N. Leff | BioWorld Today | Wednesday, December 11, 2002 -
Vaccine Against Cervical Cancer Racked Up 100 Percent Efficacy In Placebo-Controlled Human Trial
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...In a large-scale controlled clinical trial, the vaccine scored 100 percent efficacy in preventing the malignancyBy David N. Leff | BioWorld Today | Monday, November 25, 2002 -
Oral Anti-Angiogenesis Vaccine Protected Mice From Colon, Lung, Melanoma Infective Challenge
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...So far, these clinical efforts have their own drawbacks, and the search continues for effective anti-angiogenic therapies...Its clinical isolates account for 34 percent of antibiotic resistance in the U.S., much higher in parts of Asia and EuropeBy David N. Leff | BioWorld Today | Tuesday, November 12, 2002 -
FDA Tells Biogen To Clean Up Avonex Advertising Claims
The agency also cited the claim that "cognitive dysfunction is significantly correlated with brain atrophy," saying Biogen's clinical trials did not assess such a correlation...The voluntary moratorium follows suggestions by the FDA and USDA that pharmaceutical-product plants that out-cross should be grown only in regions of the country where little or none of the plant's food/feed counterparts is grown. (Corn is the subject of the moratorium because it out-crosses, meaning its pollen is spread byBy Kim Coghill | BioWorld Today | Tuesday, November 5, 2002 -
Rats' Antennae-Like Whiskers Perform Mental Arithmetic, By Neuronal Spectral Mixing
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...The main paper describes a mechanism of tumor evasion that may also apply to the impairment of other immune defense systems, and which may well have clinical potentialBy David N. Leff | BioWorld Today | Monday, October 28, 2002 -
Neural Stem Cells Go One Better Than Two Currently Understood Pluripotent Degenerative Actions
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...More than 300 patent applications have been made so far for FTase inhibitors, and six or more are currently in clinical trialsBy David N. Leff | BioWorld Today | Monday, October 21, 2002 -
Genelabs Synthesizes Family Of DNA-Binding Fungicidal Molecules
Serono SA, of Rockland, Mass., reported 24-week results from a completed clinical trial of Serostim...Phase I clinical trials with repeat dosing will now be finalized and evaluated...PDF inhibitors target an enzyme that is essential to bacteria but not required in human cells.By Karen Young | BioWorld Today | Tuesday, October 1, 2002 -
Therapeutic Cloning OK, Cloning Humans Not, Whitehead Scientists Report In 12,654-Gene RNA Survey
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...He added, "This study establishes unequivocally that the normalcy of surviving cloned animals should not be based on superficial clinical examinations, but rather on detailed molecular analysis of tissues from adult cloned animals...The controlled clinical trial enrolled 2,074 women with ovarian cancer from 130 centers in eight countriesBy David N. Leff | BioWorld Today | Monday, September 16, 2002 -
When Finished, Human Genome Sequences Will Improve Disease Management, Geneticist Predicts
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...That means a blood sample is drawn and sent to a clinical laboratoryBy David N. Leff | BioWorld Today | Monday, September 9, 2002 -
Gene Therapy For Heart Failure Pulled 59 Hamsters Back From Brink Via Transcoronary System
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...The paper concludes: "Given that there is currently no therapy for end-stage heart failure aside from heart transplantation, future studies are warranted to translate these findings into larger animal models and the clinical settingBy David N. Leff | BioWorld Today | Tuesday, September 3, 2002 -
Australian Vaccinologists Argue Toxins, Yes; Antigens, No' Show Anti-Malarial Parasite Protection
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...In contrast to acquired clinical immunity," the Nature paper points out, "anti-parasite immunity takes many years to develop and is easily lost, reflecting the problems of antigenic diversity...They point out that their in vivo experiment differs significantly from current clinical practice, suggesting that there is no immediate cause for concernBy David N. Leff | BioWorld Today | Monday, August 26, 2002 -
38 Percent Of Mice That Modeled Fatal Scrapie Prion Disease And Got Novel Drug Survived Longer
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...They showed no clinical disease 330 days after inoculation plus repeated therapy, compared with 180 days without treatmentBy David N. Leff | BioWorld Today | Monday, August 12, 2002 -
Italian Team Develops, Confirms High-Fidelity Molecules To Detect, Block Anthrax Bug's Lethal Factor
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...They make the point that the clinical presentation and outcome of anthrax in humans depend on the spore's route of entry into the bodyBy David N. Leff | BioWorld Today | Tuesday, August 6, 2002 -
To Quell HIV's Inexorable Strain Variability, Alamos Lab Proposes Country-Defined AIDS Vaccines
Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...Efforts to develop maytansine into a clinically useful anticancer drug proved disappointing in Phase II clinical trials in the 1980s, probably because of dose-limiting toxicity in humansBy David N. Leff | BioWorld Today | Monday, July 8, 2002
Category
Current Filters
- xNOT Bio Perspectives
Related Keywords
Categories
- x BioWorld Today (2573)
- x BioWorld International (51)
- x BioWorld Insight (2)
- x State of the Industry Report (2)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.